ZNF608
Summary:
| Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
|---|---|---|---|---|---|
| zinc finger protein 608 | Ensembl:ENSG00000168916 | HGNC:HGNC:29238 | PA134945727 | 5q23.2 |
GO terms in ZNF608
| Term Type | Evidence Type | GO Term ID | GO Des. |
|---|---|---|---|
| MF | IEA | GO:0003676 | nucleic acid binding |
| MF | IEA | GO:0046872 | metal ion binding |
| BP | ISS | GO:0000122 | negative regulation of transcription by RNA polymerase II |
| BP | IEA | GO:0006351 | transcription, DNA-templated |
Gene expression in normal tissue: ZNF608
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in ZNF608
| Database | Pathway ID | Pathway Des. |
|---|
Gene-Drug: Aster Plot
| Drug ID | Drug Name | Model Num. |
|---|---|---|
| iGMDRD23 | Gossypol | 4 |
| iGMDRD322 | FK 866 | 3 |
| iGMDRD60 | Quinoclamine | 2 |
| iGMDRD577 | BIX01294 | 2 |
| iGMDRD780 | PP-30 | 3 |
| iGMDRD188 | Piperlongumine | 2 |
| iGMDRD100 | Zebularine | 3 |
| iGMDRD872 | BRD7137 | 2 |
| iGMDRD77 | Itraconazole | 3 |
| iGMDRD705 | Nakiterpiosin | 3 |
| iGMDRD6 | AM-580 | 3 |
| iGMDRD105 | Triptolide | 2 |
| iGMDRD434 | BMS-536924 | 4 |
| iGMDRD945 | ML214 | 1 |
| iGMDRD466 | Chaetocin | 1 |
| iGMDRD280 | CYTOCHALASIN B | 5 |
| iGMDRD177 | Teniposide | 3 |
| iGMDRD679 | Bistramide A | 3 |
| iGMDRD698 | Neratinib | 2 |
| iGMDRD314 | Tanespimycin | 3 |
| iGMDRD61 | Kinetin riboside | 1 |
| iGMDRD152 | 179324-69-7 | 1 |
| iGMDRD446 | LY 2183240 | 2 |
| iGMDRD85 | Ursolic acid | 1 |
| iGMDRD150 | RITA | 2 |
| iGMDRD427 | ABT737 | 1 |
| iGMDRD512 | nutlin 3 | 5 |
| iGMDRD126 | Tipifarnib | 7 |
| iGMDRD554 | CHEMBL1434137 | 3 |
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in ZNF608

